Evaluation of involved proteins in colon adenocarcinoma: an interactome analysis
Gastroenterology and Hepatology from Bed to Bench,
Aim: Assessment of related genes to colon cancer to introduce crucial ones, was the aim of this research.
Background: Colon cancer is one of the invasive colorectal diseases. This disease is preventable and manageable if it be diagnosed in early stage. The aggressive tools for its detection imply more investigation for new molecular diagnostic methods.
Methods: Numbers of 300 genes from String database (SD) are analyzed via constructed Protein-protein interaction (PPI) network by Cytoscape software 3.4.0. Based on centrality parameters the main connected component of network was analyzed and the crucial genes were introduced. Cluster analysis of the network and gene ontology for the nodes of the main cluster revealed more details about the role of the key proteins related to colon cancer disease.
Results: The constructed network was consisted of 300 genes which among them 68 genes were isolated and the 232 other genes formed the main connected component. Ten crucial genes related to colon adenocarcinoma were introduced that presented in cluster 1. Gene ontology analysis showed that cluster 1 is involved in 226 biological processes which are classified in 25 groups.
Conclusion: In conclusion, results indicate that the identified key proteins play significant roles in colon adenocarcinoma. It may be possible to introduce a few diagnostic biomarker candidates for colon cancer disease.
- Colon cancer
- Gene ontology
- Hub-bottleneck nodes
- Biomarker candidate
How to Cite
O’Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007;445(7123):106-10.
Malekzadeh R, Bishehsari F, Mahdavinia M, Ansari R. Epidemiology and molecular genetics of colorectal cancer in iran: a review. Arch Iran Med. 2009;12(2):161-9.
Wexner SD, Beck DE, Baron TH, Fanelli RD, Hyman N, Shen B, et al. A consensus document on bowel preparation before colonoscopy: prepared by a task force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Diseases of the colon & rectum. 2006;49(6):792-809.
Zamanian–Azodi M, Rezaei–Tavirani M, Hasanzadeh H, RahmatiRad S, Dalilan S, Gilanchi S, et al. Introducing biomarker panel in esophageal, gastric, and colon cancers; a proteomic approach. Gastroenterology and Hepatology from bed to bench. 2014;1(1):2015-8 (1): 6-18.
Zamanian-Azodi M, Rezaei-Tavirani M, Rahmati-Rad S, Hasanzadeh H, Tavirani MR, Seyyedi SS. Protein-Protein Interaction Network could reveal the relationship between the breast and colon cancer. Gastroenterology and Hepatology from bed to bench. 2015;8(3):215.
Rezaei-Tavirani M, Zamanian-Azodi M, Rajabi S, Masoudi-Nejad A, Rostami-Nejad M, Rahmatirad S. Protein Clustering and Interactome Analysis in Parkinson and Alzheimer's Diseases. Archives of Iranian Medicine (AIM). 2016;19(2).
Yu H, Kim PM, Sprecher E, Trifonov V, Gerstein M. The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics. PLoS Comput Biol. 2007;3(4):e59.
Bonacich P. Some unique properties of eigenvector centrality. Social networks. 2007;29(4):555-64.
Leydesdorff L. Betweenness centrality as an indicator of the interdisciplinarity of scientific journals. Journal of the American Society for Information Science and Technology. 2007;58(9):1303-19.
Hou H, Kretschmer H, Liu Z. The structure of scientific collaboration networks in Scientometrics. Scientometrics. 2008;75(2):189-202.
Safari-Alighiarloo N, Rezaei-Tavirani M, Taghizadeh M, Tabatabaei SM, Namaki S. Network-based analysis of differentially expressed genes in cerebrospinal fluid (CSF) and blood reveals new candidate genes for multiple sclerosis. PeerJ. 2016;4:e2775.
Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, Goehler H, et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell. 2005;122(6):957-68.
Rual J-F, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, et al. Towards a proteome-scale map of the human protein–protein interaction network. Nature. 2005;437(7062):1173-8.
Holmans P, Green EK, Pahwa JS, Ferreira MA, Purcell SM, Sklar P, et al. Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. The American Journal of Human Genetics. 2009;85(1):13-24.
Robinson PN, Köhler S, Bauer S, Seelow D, Horn D, Mundlos S. The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease. The American Journal of Human Genetics. 2008;83(5):610-5.
Khatri P, Sirota M, Butte AJ. Ten years of pathway analysis: current approaches and outstanding challenges. PLoS Comput Biol. 2012;8(2):e1002375.
Schilling CH, Schuster S, Palsson BO, Heinrich R. Metabolic pathway analysis: basic concepts and scientific applications in the post‐genomic era. Biotechnology progress. 1999;15(3):296-303.
Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. science. 1999;286(5439):531-7.
Safari-Alighiarloo N, Taghizadeh M, Rezaei-Tavirani M, Goliaei B, Peyvandi AA. Protein-protein interaction networks (PPI) and complex diseases. Gastroenterology and Hepatology from bed to bench. 2014;7(1).
Azodi MZ, Peyvandi H, Rostami-Nejad M, Safaei A, Rostami K, Vafaee R, et al. Protein-protein interaction network of celiac disease. Gastroenterology and Hepatology from bed to bench. 2016;9(4):268.
Ardakani MJE, Safaei A, Oskouie AA, Haghparast H, Haghazali M, Shalmani HM, et al. Evaluation of liver cirrhosis and hepatocellular carcinoma using Protein-Protein Interaction Networks. Gastroenterology and Hepatology from bed to bench. 2016.
Lopes CT, Franz M, Kazi F, Donaldson SL, Morris Q, Bader GD. Cytoscape Web: an interactive web-based network browser. Bioinformatics. 2010;26(18):2347-8.
Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, et al. The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible. Nucleic Acids Research. 2016:gkw937.
Ray M, Ruan J, Zhang W. Variations in the transcriptome of Alzheimer's disease reveal molecular networks involved in cardiovascular diseases. Genome biology. 2008;9(10):R148.
Safari‐Alighiarloo N, Taghizadeh M, Tabatabaei SM, Shahsavari S, Namaki S, Khodakarim S, et al. Identification of new key genes for type 1 diabetes through construction and analysis of protein–protein interaction networks based on blood and pancreatic islet transcriptomes. Journal of diabetes. 2017;9(8):764-77.
Safari‐Alighiarloo N, Taghizadeh M, Tabatabaei SM, Shahsavari S, Namaki S, Khodakarim S, et al. Identification of new key genes for type 1 diabetes through construction and analysis of the protein‐protein interaction networks based on blood and pancreatic islet transcriptomes. Journal of Diabetes. 2016.
Spirin V, Mirny LA. Protein complexes and functional modules in molecular networks. Proceedings of the National Academy of Sciences. 2003;100(21):12123-8.
Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols. 2009;4(1):44-57.
Joyce KE, Laurienti PJ, Burdette JH, Hayasaka S. A new measure of centrality for brain networks. PLoS One. 2010;5(8):e12200.
Thomas PD, Campbell MJ, Kejariwal A, Mi H, Karlak B, Daverman R, et al. PANTHER: a library of protein families and subfamilies indexed by function. Genome research. 2003;13(9):2129-41.
Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene Ontology: tool for the unification of biology. Nature genetics. 2000;25(1):25-9.
Abbaszadeh H-A, Peyvandi AA, Sadeghi Y, Safaei A, Zamanian-Azodi M, Khoramgah MS, et al. Er: YAG Laser and Cyclosporin A Effect on Cell Cycle Regulation of Human Gingival Fibroblast Cells. Journal of Lasers in Medical Sciences. 2017;8(3):143-9.
Wang Y, Cui T, Zhang C, Yang M, Huang Y, Li W, et al. Global protein− protein interaction network in the human pathogen Mycobacterium tuberculosis H37Rv. Journal of proteome research. 2010;9(12):6665-77.
Gulmann C, Sheehan K, Kay E, Liotta L, Petricoin E. Array‐based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer. The Journal of pathology. 2006;208(5):595-606.
Nguyen T-P, Ho T-B. Detecting disease genes based on semi-supervised learning and protein–protein interaction networks. Artificial intelligence in medicine. 2012;54(1):63-71.
Safaei A, Tavirani MR, Oskouei AA, Azodi MZ, Mohebbi SR, Nikzamir AR. Protein-protein interaction network analysis of cirrhosis liver disease. Gastroenterology and Hepatology from bed to bench. 2016;9(2):114.
Taylor IW, Linding R, Warde-Farley D, Liu Y, Pesquita C, Faria D, et al. Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nature biotechnology. 2009;27(2):199-204.
Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, et al. Clues to the pathogenesis of familial colorectal cancer. Science. 1993;260(5109):812-6.
Hofvander J, Tayebwa J, Nilsson J, Magnusson L, Brosjö O, Larsson O, et al. Recurrent PRDM10 gene fusions in undifferentiated pleomorphic sarcoma. Clinical Cancer Research. 2015;21(4):864-9.
Hickman DM, MILLER RA, Rombeau JL, Twomey PL, Frey CF. Serum albumin and body weight as predictors of postoperative course in colorectal cancer. Journal of Parenteral and Enteral nutrition. 1980;4(3):314-6.
Mzoughi S, Tan YX, Low D, Guccione E. The role of PRDMs in cancer: One family, two sides. Current opinion in genetics & development. 2016;36:83-91.
Petitjean A, Achatz M, Borresen-Dale A, Hainaut P, Olivier M. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene. 2007;26(15):2157.
Phillips A, Shaper AG, Whincup P. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. The Lancet. 1989;334(8677):1434-6.
Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. The Lancet. 2005;365(9466):1231-8.
Nickolas TL, O'Rourke MJ, Yang J, Sise ME, Canetta PA, Barasch N, et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Annals of internal medicine. 2008;148(11):810-9.
Moroni M, Veronese S, Benvenuti S, Marrapese G, Sartore-Bianchi A, Di Nicolantonio F, et al. Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study. The lancet oncology. 2005;6(5):279-86.
Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase–AKT pathway in human cancer. Nature Reviews Cancer. 2002;2(7):489-501.
Dehm S, Senger M-A, Bonham K. SRC transcriptional activation in a subset of human colon cancer cell lines. FEBS letters. 2001;487(3):367-71.
Dunn EF, Iida M, Myers RA, Campbell D, Hintz K, Armstrong EA, et al. Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab. Oncogene. 2011;30(5):561-74.
Paez JG, Jänne PA, Lee JC, Tracy S, Greulich H, Gabriel S, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science. 2004;304(5676):1497-500.
Kobayashi S, Boggon TJ, Dayaram T, Jänne PA, Kocher O, Meyerson M, et al. EGFR mutation and resistance of non–small-cell lung cancer to gefitinib. N Engl J Med. 2005;2005(352):786-92.
Nicholson R, Gee J, Harper M. EGFR and cancer prognosis. European journal of cancer. 2001;37:9-15.
Yarden Y. The EGFR family and its ligands in human cancer: signalling mechanisms and therapeutic opportunities. European journal of cancer. 2001;37:3-8.
Dang CV. MYC on the path to cancer. Cell. 2012;149(1):22-35.
Shachaf CM, Kopelman AM, Arvanitis C, Karlsson A. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature. 2004;431(7012):1112.
Chen WW, Schoeberl B, Jasper PJ, Niepel M, Nielsen UB, Lauffenburger DA, et al. Input–output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data. Molecular systems biology. 2009;5(1):239.
Benvenuti S, Sartore-Bianchi A, Di Nicolantonio F, Zanon C, Moroni M, Veronese S, et al. Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti–epidermal growth factor receptor antibody therapies. Cancer research. 2007;67(6):2643-8.
Brouard S, Mansfield E, Braud C, Li L, Giral M, Hsieh S-c, et al. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proceedings of the National Academy of Sciences. 2007;104(39):15448-53.
Younossi ZM, Jarrar M, Nugent C, Randhawa M, Afendy M, Stepanova M, et al. A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH). Obesity surgery. 2008;18(11):1430-7.
Millar EK, Graham PH, O'Toole SA, McNeil CM, Browne L, Morey AL, et al. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel. Journal of clinical oncology. 2009;27(28):4701-8.
Zamanian–Azodi M, Rezaei–Tavirani M, Hasanzadeh H, Rad SR, Dalilan S. Introducing biomarker panel in esophageal, gastric, and colon cancers; a proteomic approach. Gastroenterology and Hepatology from bed to bench. 2015;8(1):6.
- Abstract Viewed: 206 times
- PDF Downloaded: 110 times